Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial
The Lancet. On line first March 9, 2015 http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)62225-X/abstract
Leggi


